EHEALTH INC (EHTH) Fundamental Analysis & Valuation

NASDAQ:EHTH • US28238P1093

1.545 USD
-0.08 (-4.63%)
At close: Mar 11, 2026
1.545 USD
0 (0%)
After Hours: 3/11/2026, 8:00:02 PM

This EHTH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall EHTH gets a fundamental rating of 3 out of 10. We evaluated EHTH against 149 industry peers in the Insurance industry. The financial health of EHTH is average, but there are quite some concerns on its profitability. EHTH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. EHTH Profitability Analysis

1.1 Basic Checks

  • In the past year EHTH has reported negative net income.
  • In the past year EHTH has reported a negative cash flow from operations.
  • In the past 5 years EHTH always reported negative net income.
  • In the past 5 years EHTH always reported negative operating cash flow.
EHTH Yearly Net Income VS EBIT VS OCF VS FCFEHTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • EHTH has a worse Return On Assets (-0.82%) than 83.22% of its industry peers.
  • With a Return On Equity value of -1.07%, EHTH is not doing good in the industry: 81.88% of the companies in the same industry are doing better.
  • EHTH has a better Return On Invested Capital (3.54%) than 63.09% of its industry peers.
Industry RankSector Rank
ROA -0.82%
ROE -1.07%
ROIC 3.54%
ROA(3y)-3.27%
ROA(5y)-6.25%
ROE(3y)-4.07%
ROE(5y)-7.56%
ROIC(3y)N/A
ROIC(5y)N/A
EHTH Yearly ROA, ROE, ROICEHTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • EHTH has a Operating Margin (12.36%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of EHTH has grown nicely.
  • EHTH does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 12.36%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y6.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EHTH Yearly Profit, Operating, Gross MarginsEHTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

5

2. EHTH Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EHTH is destroying value.
  • EHTH has more shares outstanding than it did 1 year ago.
  • EHTH has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EHTH is higher compared to a year ago.
EHTH Yearly Shares OutstandingEHTH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
EHTH Yearly Total Debt VS Total AssetsEHTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 0.98, we must say that EHTH is in the distress zone and has some risk of bankruptcy.
  • With an excellent Altman-Z score value of 0.98, EHTH belongs to the best of the industry, outperforming 81.88% of the companies in the same industry.
  • A Debt/Equity ratio of 0.12 indicates that EHTH is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.12, EHTH is in the better half of the industry, outperforming 75.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACC0.49
WACC7.21%
EHTH Yearly LT Debt VS Equity VS FCFEHTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • EHTH has a Current Ratio of 3.37. This indicates that EHTH is financially healthy and has no problem in meeting its short term obligations.
  • EHTH has a better Current ratio (3.37) than 91.28% of its industry peers.
  • EHTH has a Quick Ratio of 3.37. This indicates that EHTH is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of EHTH (3.37) is better than 91.28% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
EHTH Yearly Current Assets VS Current LiabilitesEHTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

3

3. EHTH Growth Analysis

3.1 Past

  • EHTH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.86%.
  • EHTH shows a small growth in Revenue. In the last year, the Revenue has grown by 4.06%.
  • EHTH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.01% yearly.
EPS 1Y (TTM)2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.5%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y10.97%
Revenue growth 5Y-1.01%
Sales Q2Q%3.51%

3.2 Future

  • Based on estimates for the next years, EHTH will show a very strong growth in Earnings Per Share. The EPS will grow by 130.21% on average per year.
  • The Revenue is expected to grow by 4.75% on average over the next years.
EPS Next Y656.67%
EPS Next 2Y219.63%
EPS Next 3Y130.21%
EPS Next 5YN/A
Revenue Next Year-18.14%
Revenue Next 2Y-7.21%
Revenue Next 3Y-0.1%
Revenue Next 5Y4.75%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EHTH Yearly Revenue VS EstimatesEHTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
EHTH Yearly EPS VS EstimatesEHTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4

5

4. EHTH Valuation Analysis

4.1 Price/Earnings Ratio

  • EHTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 1.36 indicates a rather cheap valuation of EHTH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EHTH indicates a rather cheap valuation: EHTH is cheaper than 93.96% of the companies listed in the same industry.
  • EHTH is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1.36
EHTH Price Earnings VS Forward Price EarningsEHTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • EHTH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EHTH is cheaper than 97.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1
EHTH Per share dataEHTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as EHTH's earnings are expected to grow with 130.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y219.63%
EPS Next 3Y130.21%

0

5. EHTH Dividend Analysis

5.1 Amount

  • EHTH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EHTH Fundamentals: All Metrics, Ratios and Statistics

EHEALTH INC

NASDAQ:EHTH (3/11/2026, 8:00:02 PM)

After market: 1.545 0 (0%)

1.545

-0.08 (-4.63%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners71.01%
Inst Owner Change-4.15%
Ins Owners4.6%
Ins Owner Change2.77%
Market Cap48.00M
Revenue(TTM)554.01M
Net Income(TTM)-10.40M
Analysts50
Price Target7.48 (384.14%)
Short Float %3.84%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.77%
Min EPS beat(2)-3.64%
Max EPS beat(2)2.1%
EPS beat(4)3
Avg EPS beat(4)16.25%
Min EPS beat(4)-3.64%
Max EPS beat(4)53.86%
EPS beat(8)4
Avg EPS beat(8)-0.04%
EPS beat(12)6
Avg EPS beat(12)0.22%
EPS beat(16)10
Avg EPS beat(16)9.34%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.5%
Max Revenue beat(2)-0.47%
Revenue beat(4)2
Avg Revenue beat(4)9.74%
Min Revenue beat(4)-1.5%
Max Revenue beat(4)29.61%
Revenue beat(8)5
Avg Revenue beat(8)9.49%
Revenue beat(12)8
Avg Revenue beat(12)10.36%
Revenue beat(16)10
Avg Revenue beat(16)6.46%
PT rev (1m)0%
PT rev (3m)-13.73%
EPS NQ rev (1m)-24.74%
EPS NQ rev (3m)-23.47%
EPS NY rev (1m)181.86%
EPS NY rev (3m)181.86%
Revenue NQ rev (1m)-14.96%
Revenue NQ rev (3m)-14.96%
Revenue NY rev (1m)-16.98%
Revenue NY rev (3m)-17.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.36
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB 0.05
EV/EBITDA 1
EPS(TTM)-0.2
EYN/A
EPS(NY)1.14
Fwd EY73.5%
FCF(TTM)-1.31
FCFYN/A
OCF(TTM)-0.82
OCFYN/A
SpS17.83
BVpS31.34
TBVpS31.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.82%
ROE -1.07%
ROCE 5.89%
ROIC 3.54%
ROICexc 3.79%
ROICexgc 3.79%
OM 12.36%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.27%
ROA(5y)-6.25%
ROE(3y)-4.07%
ROE(5y)-7.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-0.96%
ROICexc growth 3YN/A
ROICexc growth 5Y0.4%
OM growth 3YN/A
OM growth 5Y6.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 1.37
Cap/Depr 111.27%
Cap/Sales 2.76%
Interest Coverage 7.68
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 0.98
F-Score2
WACC7.21%
ROIC/WACC0.49
Cap/Depr(3y)81.36%
Cap/Depr(5y)85.62%
Cap/Sales(3y)2.52%
Cap/Sales(5y)3.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.5%
EPS Next Y656.67%
EPS Next 2Y219.63%
EPS Next 3Y130.21%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y10.97%
Revenue growth 5Y-1.01%
Sales Q2Q%3.51%
Revenue Next Year-18.14%
Revenue Next 2Y-7.21%
Revenue Next 3Y-0.1%
Revenue Next 5Y4.75%
EBIT growth 1Y107.28%
EBIT growth 3YN/A
EBIT growth 5Y5.15%
EBIT Next Year10.85%
EBIT Next 3Y15.52%
EBIT Next 5YN/A
FCF growth 1Y-30.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38%
OCF growth 3YN/A
OCF growth 5YN/A

EHEALTH INC / EHTH FAQ

What is the ChartMill fundamental rating of EHEALTH INC (EHTH) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EHTH.


What is the valuation status of EHEALTH INC (EHTH) stock?

ChartMill assigns a valuation rating of 5 / 10 to EHEALTH INC (EHTH). This can be considered as Fairly Valued.


What is the profitability of EHTH stock?

EHEALTH INC (EHTH) has a profitability rating of 1 / 10.


Can you provide the financial health for EHTH stock?

The financial health rating of EHEALTH INC (EHTH) is 5 / 10.